Reinvent the Role of Corporate Counsel as Solution-Oriented, Value-Creating, Strategic Partners to a Cutting Edge, Innovation-Centric, Scientific Community
Now in its second year, In-House Impact: Life Sciences is the only digital-only global forum dedicated to life sciences legal leaders accelerating their journey (and that of their teams) from legal specialist to strategic business partner.
It is a unique opportunity to gather with your peers in pharma, biotech and medical device in-house legal teams to collaborate and carve out a new narrative for the legal function – from enterprise defenders to integrated enablers of innovation.
Uncover how the most high-impact legal teams are embedding innovation, collaboration and creativity into their DNA, sharing exactly how that’s allowing them to move from minimizing risk to maximizing opportunity in operating as true partners to their rapidly growing scientific business and helping them get better drugs to patients faster.
Secure your place at this unique open forum to listen to and be involved in discussions that are transforming the future of legal leadership and service delivery in life sciences businesses.
Expert Speakers Include:
Corporate Vice President & General Counsel
Chief Legal & Business Officer
Assembly Biosciences (USA)
Corporate Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer
Charles River Laboratories
5 Unmissable Highlights
Taking Chances & Minimizing Risk:
Explore how leaders from Novo Nordisk, Thermo Fisher Scientific, Assembly Biosciences and Eli Lilly & Co have leveraged experiences in business or dual roles to move beyond being a lawyer, to become true strategic partner and commercial business leader.
A Value-Creating Function:
Uncover how in-house counsel from hyper-growth life sciences organizations like Amyris, Repligen
Corporation and Intercept Pharmaceuticals are building trust, increasing influence, and doing
more with less in order to have greater business impact.
Driving Innovation Within Legal:
Get inspired by how Novartis, Thermo Fisher Scientific and Bristol-Myers Squibb are leveraging legal operational excellence, technology and data to build future-ready legal teams.
GC Career Stories & Insights:
Attend the pre-conference ‘Next-Gen Corporate Counsel’ focus day to listen to leaders from GSK, Charles River Laboratories and TCR2 Therapeutics discuss the skills, experiences and capabilities required of the future life sciences in-house leader.
Once you’ve registered your pass, you’ll get access to the recordings of the four best presentations from the November 2020 virtual conference from leading life sciences businesses like Roche Diagnostics, Spark Therapeutics, Schrödinger
'Most of us have access to a small number of fellow GCs we can reach out to for advice, but very few of us are part of a wider industry-specific community of GCs able to discuss and debate the future of our legal function. This is why I’m excited to be a part of In-House Impact: Life Sciences, to enhance and facilitate those invaluable relationships.'
Jonathan Biller, Chief Legal Officer, Agios Pharmaceuticals
'Geared specifically towards General Counsels and their inhouse teams within Life Sciences, In-House Impact looks set to occupy a unique and invaluable space in the industry.'
Marcela Kirberger, General Counsel & Secretary, Roche Diagnostics Corporation
'In-House Impact: Life Sciences is a useful forum for in-house legal leaders to share practical experiences on how to best collaborate with other business partners to deliver and create value to employees, the organization and stockholders.'
Jason Okazaki, Chief Legal & Business Officer, Assembly Biosciences
'Experiencing alone the journey from start-up to the rapid scaling of a fast-growth organization can be an intimidating process, but with this unique opportunity to engage with other GCs from across the Life Sciences, I’m excited to be a part of In-House Impact: Life Sciences, and discover what my peers are doing to find success through rapid change.'
Dina Ciarimboli, General Counsel, Third Rock Ventures